コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ecently been reported to cause severe, often lethal disease.
2 le-strand breaks in DNA, and cause invasive, lethal disease.
3 sponse, resistant mice became susceptible to lethal disease.
4 entially be repurposed for treatment of this lethal disease.
5 ptions and the poor prognosis of this common lethal disease.
6 omising new biologic approach to combat this lethal disease.
7 ed follow-up and an emphasis on advanced and lethal disease.
8 d in the clinical care of patients with this lethal disease.
9 lls is needed to effectively protect against lethal disease.
10 Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease.
11 successfully treating this almost invariably lethal disease.
12 uest the liver cancer, a currently incurable lethal disease.
13 of H1 and H5 subtypes and protect mice from lethal disease.
14 tment of pancreatic adenocarcinoma, a highly lethal disease.
15 ave failed to protect nonhuman primates from lethal disease.
16 block tumor progression is critical for this lethal disease.
17 mmune responses that protect animals against lethal disease.
18 Pancreatic ductal adenocarcinoma (PDA) is a lethal disease.
19 ered patient with COVID-19 protected against lethal disease.
20 ent in OX40 signals still eventually develop lethal disease.
21 represent therapeutic targets in this highly lethal disease.
22 , effective, and targeted therapies for this lethal disease.
23 -induced inflammation and protecting against lethal disease.
24 f these inflammatory cytokines prevented the lethal disease.
25 al and appealing therapeutic target for this lethal disease.
26 and that CD4+ T cells were unable to induce lethal disease.
27 more likely (95% CI, 2.3 to 128) to develop lethal disease.
28 gral to the hallmark invasive nature of this lethal disease.
29 olved in T-cell exhaustion and prevention of lethal disease.
30 ally heterogeneous, ranging from indolent to lethal disease.
31 hts into the development of this potentially lethal disease.
32 was able to completely protect rabbits from lethal disease.
33 ariability, ranging from silent infection to lethal disease.
34 e and its ramifications for the cure of this lethal disease.
35 cerns about the potential pandemic spread of lethal disease.
36 to either a mild, self-limiting infection or lethal disease.
37 ants which lead to either viral clearance or lethal disease.
38 of patients with this highly infectious and lethal disease.
39 velopment of therapeutic approaches for this lethal disease.
40 alignant melanoma is a common and frequently lethal disease.
41 y and economically costly, and a potentially lethal disease.
42 SmCC of the GI tract is a rare and lethal disease.
43 key sera protected 100% of the hamsters from lethal disease.
44 linically silent encephalitis into uniformly lethal disease.
45 ating that antibodies alone can protect from lethal disease.
46 mbinant allele was associated with perinatal lethal disease.
47 ly protected from the development of acutely lethal disease.
48 with FK-506 were not protected from acutely lethal disease.
49 iagnose, and treat this rare but potentially lethal disease.
50 induce lymphocyte proliferation and acutely lethal disease.
51 drocortisone results in an acute, fulminant, lethal disease.
52 ective therapies are needed for this rapidly lethal disease.
53 mpt to improve the cure rate for this highly lethal disease.
54 rgp120-immunized animals were protected from lethal disease.
55 rapy for patients suffering from this highly lethal disease.
56 resistant to cytotoxic chemotherapy and is a lethal disease.
57 therapeutic target for the treatment of this lethal disease.
58 btype that is associated with progression to lethal disease.
59 ecades, metastatic prostate cancer remains a lethal disease.
60 mmune checkpoint inhibitors in this globally lethal disease.
61 e metastatic setting, ccRCC remains a highly lethal disease.
62 inst late-stage prostate cancer, a currently lethal disease.
63 as targetable vulnerabilities in this highly lethal disease.
64 was strongly associated with higher risk of lethal disease.
65 sociated with a lower risk of progression to lethal disease.
66 ial therapy with potential efficacy for this lethal disease.
67 n receptor (AR) antagonist enzalutamide is a lethal disease.
68 eras to treat a specific, identifiable, and lethal disease.
69 viable alternative in the treatment of this lethal disease.
70 asive bladder cancer (MIBC) is a potentially lethal disease.
71 he host, from asymptomatic to severe or even lethal disease.
72 mostly harmless endemic virus gives rise to lethal disease.
73 igher in the ~50% of tumors that progress to lethal disease.
74 ed 100% of guinea pigs against JUNV and GTOV lethal disease.
75 pport productive EBOV replication or develop lethal disease.
76 its therapeutic potential in combatting this lethal disease.
77 ential for clinical translation against this lethal disease.
78 prostate cancer with biochemical relapse and lethal disease.
79 dvanced breast cancers that have resulted in lethal disease.
80 he great need for better treatments for this lethal disease.
81 ation for more effective treatments for this lethal disease.
82 not protect Mavs(-/-) mice from WNV-induced lethal disease.
83 radicating smallpox, one of the world's most lethal diseases.
84 ncreasing numbers of patients with otherwise lethal diseases.
85 ment of hepatocellular carcinoma (HCC), both lethal diseases.
86 echanism of pathogenesis in these common and lethal diseases.
87 in life is associated with severe, sometimes lethal, disease.
88 ts exhibited moderate to severe, potentially lethal, disease.
91 le-negative breast cancer are among the most lethal diseases affecting women, with few targeted thera
92 tected 100% of EBOV-infected animals against lethal disease, ameliorating clinical disease signs and
93 of prognosis, we could improve prediction of lethal disease among men with moderate Gleason 7 tumors,
94 Oral squamous cell carcinoma (OSCC) is a lethal disease and early death usually occurs as a resul
95 completely protected mice of three ages from lethal disease and effected more-rapid virus clearance.
100 virus pose the threat of pandemic spread of lethal disease and make it a priority to develop safe an
101 0% of patients with high-risk HRNMIBC have a lethal disease and may be better treated by primary radi
102 he mouse Ace2 locus in a manner that confers lethal disease and permits cell-specific, Cre-mediated l
103 treatment, which protected all animals from lethal disease and reduced serum and tissue viral loads
104 H7N9 viruses, including association between lethal disease and spread to the alveolar spaces and kid
106 ffect is not sufficient to protect mice from lethal disease, and this therapeutic approach requires f
107 s is thus central to the development of this lethal disease, and, more generally, could play an impor
112 ure significantly improved the prediction of lethal disease beyond knowing whether the Gleason score
113 BOV GP) are implicated in protection against lethal disease, but the characteristics of the human ant
114 within T-cell activation pathways to prevent lethal disease by inappropriate responses against dissem
117 evere combined immunodeficiency (XSCID) is a lethal disease caused by a defect in the gene encoding t
118 intranasal administration protects mice from lethal disease caused by a number of different influenza
121 ein-losing enteropathy (CHAPLE disease) is a lethal disease caused by genetic loss of the complement
122 , enteropathy, X-linked (IPEX) syndrome is a lethal disease caused by mutations in a transcription fa
128 7BL/6 (B6) mice are resistant to mousepox, a lethal disease caused by the orthopoxvirus ectromelia vi
129 oach, Amorim et al. studied the abundance of lethal disease-causing mutations in humans and found tha
130 f pancreatic ductal adenocarcinoma, a highly lethal disease characterized by a robust fibroinflammato
132 ulmonary fibrosis (IPF) is a progressive and lethal disease characterized by excessive extracellular
133 Pulmonary arterial hypertension (PAH) is a lethal disease characterized by excessive proliferation
134 human respiratory coronaviruses cause acute lethal disease characterized by exuberant inflammatory r
135 y death) syndrome is a recessively inherited lethal disease characterized by fetal growth retardation
137 Advanced urothelial cancer is a frequently lethal disease characterized by marked genetic heterogen
139 ight chains leads to systemic amyloidosis, a lethal disease characterized by the formation of amyloid
140 nfection of FK506-treated mice resulted in a lethal disease characterized by viremia, lack of serocon
141 Pancreatic cancer is an almost uniformly lethal disease, characterized by late diagnosis, early m
142 ight loss, whereas 11SB23 produces acute and lethal disease closely resembling that observed with Cri
143 we show that mice expressing hTfR1 develop a lethal disease course marked by an increase in serum IFN
144 8 to 10; RR, 1.22; 95% CI, 1.03 to 1.45) and lethal disease (death or distant metastasis; RR, 1.19; 9
147 th low doses of virus results in a uniformly lethal disease even though little infection is detected
151 bacterial dose required to produce an acute lethal disease following intraperitoneal infection of mi
152 frican swine fever is a contagious and often lethal disease for domestic pigs with a significant econ
153 th neuroendocrine differentiation (NED) is a lethal disease for which effective therapies are urgentl
154 -grade serous ovarian carcinoma (HGSOC) is a lethal disease for which improved screening and treatmen
156 We found that Muc2-deficient mice succumb to lethal disease from ETBF colonization in a B. fragilis t
159 which henipaviruses cause severe and usually lethal disease, HeV and NiVs caused only mild or asympto
160 y microRNAs (miRs) modulating AR activity in lethal disease, hormone-responsive and -resistant PC cel
163 hemorrhagic fever virus (SHFV) causes highly lethal disease in Asian macaques resembling human illnes
165 lphaherpesvirus, is the causative agent of a lethal disease in chickens characterized by generalized
166 uctal adenocarcinoma (PDAC) remains a highly lethal disease in critical need of new therapeutic strat
167 t ASFV strains cause a highly infectious and lethal disease in domestic pigs for which there is no va
169 s compared with Chile-9717869, did not cause lethal disease in hamsters, and showed reduced ability t
172 d from animal reservoirs to cause severe and lethal disease in humans, but there are currently no FDA
173 atory syndrome coronavirus (SARS-CoV) causes lethal disease in humans, which is characterized by exac
178 mice but was completely defective in causing lethal disease in IL-1R(-/-) mice, indicating that the p
185 ogen Vibrio coralliilyticus causes a rapidly lethal disease in N. vectensis and that heat-inactivated
187 an swine fever virus (ASFV) can cause highly lethal disease in pigs and is becoming a global threat.
194 utations, one of which resulted in perinatal lethal disease in three families, were associated with c
197 Testudinid herpesvirus 3 (TeHV-3) causes a lethal disease in tortoises, several species of which ar
201 nted DIV vaccine provides protection against lethal disease in young animals following homologous and
202 uding slow bee paralysis virus (SBPV), cause lethal diseases in honeybees and bumblebees, resulting i
204 African trypanosomes-parasites that cause lethal diseases in humans and livestock-employ an antige
205 ted in the near eradication of many formerly lethal diseases in many countries, including the complet
207 o metastases and death from prostate cancer (lethal disease) in 403 patients and found the strongest
208 tibody, transformed transient myocarditis to lethal disease, in association with widespread polymorph
209 Pancreatic ductal adenocarcinoma (PDA) is a lethal disease, in part, because of the lack of effectiv
210 all types of blood cell--can treat numerous lethal diseases, including leukaemias and lymphomas.
213 ns (such as studies of late-onset or rapidly lethal diseases), it may be more practical to identify f
215 macaques unexpectedly survived this usually lethal disease, making it possible to compare physiologi
216 absence of perforin, vaccination resulted in lethal disease mediated by dysregulated CD8(+) T cell ex
217 sults in an asymptomatic infection; the only lethal disease model for a pathogenic hantavirus is Ande
218 l muscular dystrophy, a much more severe and lethal disease model, does not improve all aspects of mu
221 ia-specific CD8 T cells eradicated otherwise lethal disease more efficiently than wild-type cells and
223 virus 3 (CyHV-3) is the causative agent of a lethal disease of carp and encodes for an Il10 homolog (
224 etiological agent of a contagious and often lethal disease of domestic pigs that has significant eco
229 African swine fever virus (ASFV) causes a lethal disease of pigs with high economic impact in affe
231 s marinus is the causative agent of Dermo, a lethal disease of the eastern oyster Crassostrea virgini
233 Juvenile myelomonocytic leukemia (JMML) is a lethal disease of young children characterized by hypers
234 high degree of infectivity but did not cause lethal disease or exhibit extrapulmonary virus spread.
237 nt peritoneal mesothelioma (DMPM), a rapidly lethal disease, poorly responsive to conventional therap
238 have been partially or fully characterized, lethal disease predominantly involves a variety of strai
239 g ML-IAP expression by immunohistochemistry, lethal disease progression was associated with the loss
242 ry, facilitating long-term remission of this lethal disease.Significance: Coordinated neoadjuvant and
245 f critical importance in diagnosis of common lethal diseases such as malaria, tuberculosis, HIV, and
246 rome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19
248 ic ductal adenocarcinoma (PDA) constitutes a lethal disease that affects >30,000 people annually in t
249 gue (BT) is a debilitating and in many cases lethal disease that affects ruminants of economic import
250 ted with ANDV, but not SNV, develop a highly lethal disease that closely resembles HPS in humans.
253 c fibrosis (CF), an inherited and eventually lethal disease that impairs the function of multiple org
255 Argentine hemorrhagic fever is a potentially lethal disease that is caused by Junin virus (JUNV).
256 Amyotrophic lateral sclerosis (ALS) is a lethal disease that is characterized by the relentless d
257 ter understanding of the development of this lethal disease that is currently without efficient treat
258 atic ductal adenocarcinoma (PDA) is a highly lethal disease that is refractory to medical interventio
259 ed necrotizing pancreatitis is a potentially lethal disease that is treated with the use of a step-up
260 ed necrotising pancreatitis is a potentially lethal disease that nearly always requires intervention.
261 tor problems, in contrast to the wasting and lethal disease that occur during acute infection of immu
262 hospholipid syndrome (CAPS) is a potentially lethal disease that presents with rapidly progressive mu
263 s) are a group of genetically heterogeneous, lethal diseases that are characterized by neuronal, hepa
264 ian and uterine serous cancers are extremely lethal diseases that often present at an advanced stage.
266 Phenotypes range from complete resistance to lethal disease to severe hemorrhagic fever characterized
267 heir hosts, which range from severe and even lethal disease to subclinical or nonpathogenic infection
268 ludes the definitive assignment of this male-lethal disease to the X chromosome and the mapping of a
270 from the Old World bringing novel and hence, lethal diseases to the New World, a foretaste, perhaps,
276 te promyelocytic leukemia, formerly a highly lethal disease, was recently shown to be highly responsi
277 ntify potential therapeutic targets for this lethal disease we investigated the contribution of B cel
278 Neither EIAV(17SU) nor EIAV(17TM) produced lethal disease when administered at infectious doses tha
279 tibility of Hartley guinea pigs to uniformly lethal disease when challenged with as few as 4 PFU of t
281 nits (NAU)/kg of FFP-protected hamsters from lethal disease when given up to 8 days after intranasal
284 development of effective therapies for this lethal disease, which is refractory to standard treatmen
285 d in animals experiencing lung pathology and lethal disease, while the same animals experienced downr
286 pted Zaire ebolavirus (ZEBOV) caused rapidly lethal disease; wild-type ZEBOV and Sudan Ebolavirus and
287 Oral squamous cell carcinoma (OSCC) is a lethal disease with a 5-year mortality rate of around 50
290 Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and drug resp
293 sceptible to infection with LASV and develop lethal disease with pathology similar to that reported i
297 95% CIs of total, advanced, high-grade, and lethal disease, with adjustment for a variety of possibl
299 Pancreatic ductal adenocarcinoma (PDA) is a lethal disease, with surgery being the only curative mod